Although cardiovascular disease remains the leading proximate cause of death in the United States, it is now estimated that obesity may be equivalent to smoking as the leading cause of preventable death in America. In light of these statistics, this reference presents our current understanding of the epidemiology, pathology, and genetics of the obesity epidemic and its relationship to cardiovascular disease. It provides an evidence-based approach to the topic, as well as emphasizes a combined treatment strategy for patients suffering from both obesity and cardiovascular disease.
Overview of the Obesity Epidemic and Its Relationship to Cardiovascular Disease. Obesity and Hypertension. Insulin Resistance, Obesity, Body Fat Distribution and the Risk of Cardiovascular Disease. Lipids, Obesity, and Cardiovascular Disease. Vascular Dysfunction and Obesity. Inflammation, Fibrosis, Thrombosis, Obesity and Cardiovascular Disease. Obstructive Sleep Apnea in Obesity and Cardiovascular Disease. The Genetics of Obesity and Cardiovascular Disease. Risk Assessment and Treatment Standards of Overweight and Obese Individuals. Roles of Dietary Fats in Reducing Weight and Cardiovascular Risk Factors in Overweight and Obese Individuals. Dietary Interventions and Monitoring of Obese Patients with Cardiovascular Disease. Lifestyle Modification in the Obese Patient with Cardiovascular Disease. Use of Antiobesity Medications in Overweight Patients with Cardiovascular Disease: Implications of Drug Selection and Patient Monitoring. Gastric Bypass Surgery. Management of Preoperative Cardiac Risk in the Bariatric Surgical Patient. Atherosclerotic Disease and Obesity. Heart Failure and Obesity: The Risk of Development of Heart Failure from Obesity and the Treatment of Heart Failure in the Obese Patient. Acknowledging and Reversing the Toxic Environment